# CytoSorbents Announces $6.25 Million Common Stock Financing Priced At-the-Market under Nasdaq Rules and Concurrent Restructuring of Avenue Capital Credit Facility

- Source: PR Newswire M&A
- Published: 2026-11-20T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/cytosorbents-announces-6-25-million-common-stock-financing-priced-at-the-market-under-nasdaq-rules-and-concurrent-restructuring-of-avenue-capital-credit-facility-302946616.html
- Canonical: https://groundlevelnews.com/story/cytosorbents-announces-6-25-million-common-stock-financing-priced-at-t-1d815a/

$4.0 million registered direct offering of common stock, led by existing shareholders and management $2.25 million of Avenue debt satisfied through the issuance of common stock at the same offering price Total debt reduced by $5.25 million, to $12.25 million, saving approximately $0.7...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
